Clinical trial
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
NCT04875026 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
- Lead sponsor
- Pierre Fabre Medicament
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 16, 2021
- Completion date
- January 31, 2022
- Enrollment
- 146 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratoses